华纳药厂
(688799)
| 流通市值：72.78亿 | | | 总市值：72.78亿 |
| 流通股本：1.31亿 | | | 总股本：1.31亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 188,260,468.18 | 203,778,427.66 | 195,941,291.03 | 185,397,006.45 |
| 交易性金融资产 | 20,000,000 | 10,000,000 | 100,000,000 | 10,000,000 |
| 应收票据及应收账款 | 179,459,611.65 | 221,249,723.8 | 207,704,605.86 | 207,501,989.76 |
| 其中：应收票据 | 4,338,023.59 | 10,873,123.68 | 12,283,479.87 | 14,182,092.35 |
| 应收账款 | 175,121,588.06 | 210,376,600.12 | 195,421,125.99 | 193,319,897.41 |
| 应收款项融资 | 56,662,131.1 | 57,853,909.17 | 25,480,350.58 | 19,982,069.53 |
| 预付款项 | 19,295,547.79 | 17,895,399.66 | 21,293,191.43 | 19,616,494.16 |
| 其他应收款合计 | 3,554,626.41 | 3,207,317.96 | 12,643,226.44 | 3,929,786.82 |
| 存货 | 390,969,970.83 | 392,460,282.27 | 410,995,449.94 | 414,059,825.52 |
| 一年内到期的非流动资产 | 86,714,944.44 | 129,774,930.56 | - | - |
| 其他流动资产 | 161,770,251.68 | 140,005,388.85 | 452,242,636.18 | 492,635,433.89 |
| 流动资产合计 | 1,106,687,552.08 | 1,176,225,379.93 | 1,426,300,751.46 | 1,353,122,606.13 |
| 非流动资产: | | | | |
| 其他债权投资 | 455,955,222.91 | 353,980,429.85 | - | - |
| 长期股权投资 | 185,730,999.99 | 188,209,604.18 | 202,082,133.12 | 67,605,243.72 |
| 投资性房地产 | 6,690,909.76 | 6,742,862.05 | 5,617,725.47 | 5,659,846.22 |
| 固定资产 | 671,352,274.72 | 678,946,584.19 | 499,886,589.19 | 519,517,089.98 |
| 在建工程 | 505,153,225.81 | 323,730,017.47 | 275,496,023.03 | 228,776,605.43 |
| 无形资产 | 167,184,889.09 | 168,590,357.86 | 165,276,788.3 | 182,507,217.73 |
| 开发支出 | 29,351,838.83 | 13,956,944.74 | 9,863,428.92 | 5,724,446.37 |
| 商誉 | - | - | - | 32,381,982.12 |
| 长期待摊费用 | 11,056,813.16 | 10,987,461.08 | 8,933,675.33 | 10,125,138.94 |
| 递延所得税资产 | 37,481,642.39 | 40,450,500.63 | 28,516,873.81 | 32,248,332.93 |
| 其他非流动资产 | 63,529,815.28 | 91,823,326.88 | 158,870,186.96 | 87,938,079.94 |
| 非流动资产合计 | 2,133,487,631.94 | 1,877,418,088.93 | 1,354,543,424.13 | 1,172,483,983.38 |
| 资产总计 | 3,240,175,184.02 | 3,053,643,468.86 | 2,780,844,175.59 | 2,525,606,589.51 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 162,124,254.12 | 181,525,393.79 | 99,036,824.15 | 109,027,443.81 |
| 应付账款 | 162,124,254.12 | 181,525,393.79 | 99,036,824.15 | 109,027,443.81 |
| 预收款项 | 9,494,790.18 | 7,554,109.18 | 17,547,105.55 | 15,822,933.53 |
| 合同负债 | 69,162,853.77 | 64,929,570.22 | 78,337,291.83 | 81,958,355.07 |
| 应付职工薪酬 | 14,528,096.46 | 29,428,190.34 | 15,169,366.36 | 14,453,001.72 |
| 应交税费 | 3,871,345.54 | 12,317,448.61 | 18,737,369.48 | 12,306,237.37 |
| 其他应付款合计 | 121,847,182.55 | 101,082,358.75 | 88,765,151.79 | 88,059,279.15 |
| 一年内到期的非流动负债 | 521,856.28 | 370,999.84 | 229,465.24 | 139,981.58 |
| 其他流动负债 | 9,618,588.22 | 13,494,714.14 | 16,939,991.02 | 14,270,823.46 |
| 流动负债合计 | 391,168,967.12 | 410,702,784.87 | 334,762,565.42 | 336,038,055.69 |
| 非流动负债: | | | | |
| 长期借款 | 672,002,536.47 | 497,604,309.47 | 352,180,598.74 | 235,673,102.52 |
| 递延收益 | 101,172,917.54 | 102,651,476.91 | 101,780,781.48 | 95,744,971.86 |
| 非流动负债合计 | 773,175,454.01 | 600,255,786.38 | 453,961,380.22 | 331,418,074.38 |
| 负债合计 | 1,164,344,421.13 | 1,010,958,571.25 | 788,723,945.64 | 667,456,130.07 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 131,320,000 | 131,320,000 | 131,320,000 | 131,320,000 |
| 资本公积 | 876,365,903.55 | 870,097,017.95 | 850,688,125.6 | 835,869,925.6 |
| 盈余公积 | 50,809,979.99 | 50,809,979.99 | 46,900,000 | 46,900,000 |
| 未分配利润 | 1,017,334,879.35 | 990,457,899.67 | 963,212,104.35 | 827,204,059.21 |
| 归属于母公司股东权益合计 | 2,075,830,762.89 | 2,042,684,897.61 | 1,992,120,229.95 | 1,841,293,984.81 |
| 少数股东权益 | - | - | - | 16,856,474.63 |
| 股东权益合计 | 2,075,830,762.89 | 2,042,684,897.61 | 1,992,120,229.95 | 1,858,150,459.44 |
| 负债和股东权益合计 | 3,240,175,184.02 | 3,053,643,468.86 | 2,780,844,175.59 | 2,525,606,589.51 |
| 公告日期 | 2026-04-21 | 2026-04-21 | 2025-10-31 | 2025-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |